These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19622458)

  • 1. In vitro susceptibility of nondermatophyte molds isolated from onycomycosis to antifungal drugs.
    Trovato L; Rapisarda MF; Greco AM; Galata F; Oliveri S
    J Chemother; 2009 Aug; 21(4):403-7. PubMed ID: 19622458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro antifungal susceptibility profile of Scopulariopsis brevicaulis isolated from onychomycosis].
    Carrillo-Muñoz AJ; Tur-Tur C; Cárdenes D; Rojas F; Giusiano G
    Rev Esp Quimioter; 2015 Aug; 28(4):210-3. PubMed ID: 26200030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature.
    Gupta AK; Gregurek-Novak T; Konnikov N; Lynde CW; Hofstader S; Summerbell RC
    J Cutan Med Surg; 2001; 5(3):206-10. PubMed ID: 11685666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the antimicrobial susceptibility of fungi responsible for onychomycosis in Spain.
    Zalacain A; Obrador C; Martinez JP; Viñas M; Vinuesa T
    Med Mycol; 2011 Jul; 49(5):495-9. PubMed ID: 21142899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: a multicenter study with 36 patients.
    De Doncker PR; Scher RK; Baran RL; Decroix J; Degreef HJ; Roseeuw DI; Havu V; Rosen T; Gupta AK; Piérard GE
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):173-7. PubMed ID: 9039163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusarium spp. as agents of onychomycosis in immunocompetent hosts.
    Guilhermetti E; Takahachi G; Shinobu CS; Svidzinski TI
    Int J Dermatol; 2007 Aug; 46(8):822-6. PubMed ID: 17651164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspergillus versicolor as cause of onychomycosis: report of 12 cases and susceptibility testing to antifungal drugs.
    Torres-Rodríguez JM; Madrenys-Brunet N; Siddat M; López-Jodra O; Jimenez T
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):25-31. PubMed ID: 9731962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal susceptibility patterns of yeasts and filamentous fungi isolated from nail infection.
    Ataides FS; Chaul MH; El Essal FE; Costa CR; Souza LK; Fernandes OF; Silva MR
    J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1479-85. PubMed ID: 22049990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind, comparative study on efficacy and safety of itraconazole pulse therapy and terbinafine pulse therapy on nondermatophyte mold onychomycosis: A study with 90 patients.
    Ranawaka RR; Nagahawatte A; Gunasekara TA; Weerakoon HS; de Silva SH
    J Dermatolog Treat; 2016 Aug; 27(4):364-72. PubMed ID: 26651495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Other fungi causing onychomycosis.
    Moreno G; Arenas R
    Clin Dermatol; 2010 Mar; 28(2):160-3. PubMed ID: 20347658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.
    Jo Siu WJ; Tatsumi Y; Senda H; Pillai R; Nakamura T; Sone D; Fothergill A
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1610-6. PubMed ID: 23318803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases.
    Tosti A; Piraccini BM; Lorenzi S
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):217-24. PubMed ID: 10642676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.
    Carrillo-Muñoz AJ; Giusiano G; Cárdenes D; Hernández-Molina JM; Eraso E; Quindós G; Guardia C; del Valle O; Tur-Tur C; Guarro J
    Int J Antimicrob Agents; 2008 Jun; 31(6):540-3. PubMed ID: 18367383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Great toenail onychomycosis caused by Syncephalastrum racemosum.
    Pavlović MD; Bulajić N
    Dermatol Online J; 2006 Jan; 12(1):7. PubMed ID: 16638375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization and antifungal activity against non-dermatophyte molds causing onychomycosis.
    Pakshir K; Kamali M; Nouraei H; Zomorodian K; Motamedi M; Mahmoodi M
    Sci Rep; 2021 Oct; 11(1):20736. PubMed ID: 34671053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular typing and antifungal susceptibility of Trichophyton rubrum isolates from patients with onychomycosis pre- and post-treatment.
    de Assis Santos D; de Carvalho Araújo RA; Kohler LM; Machado-Pinto J; Hamdan JS; Cisalpino PS
    Int J Antimicrob Agents; 2007 May; 29(5):563-9. PubMed ID: 17331707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of in vitro resistance in patients with onychomycosis who fail antifungal therapy.
    Gupta AK; Kohli Y
    Dermatology; 2003; 207(4):375-80. PubMed ID: 14657630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro biofilms and antifungal susceptibility of dermatophyte and non-dermatophyte moulds involved in foot mycosis.
    Toukabri N; Corpologno S; Bougnoux ME; El Euch D; Sadfi-Zouaoui N; Simonetti G
    Mycoses; 2018 Feb; 61(2):79-87. PubMed ID: 28940733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents.
    Baudraz-Rosselet F; Ruffieux C; Lurati M; Bontems O; Monod M
    Dermatology; 2010; 220(2):164-8. PubMed ID: 20110639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.